As patents on weight-loss drugs expire, doctors and patients hotly anticipate cheaper generics
Now that patents have expired, generic versions of Novo Nordisk's blockbuster weight-loss drugs could arrive in Canada within months, according to experts. Doctors say these cheaper versions will improve access and could also change societal perceptions around weight loss and reduce the cost and burden on the health-ca...
https://www.cbc.ca/news/health/generic-ozempic-canada-waiting-9.7142339?cmp=rss
As patents on weight-loss drugs expire, doctors and patients hotly anticipate cheaper generics
Now that patents have expired, generic versions of Novo Nordisk's blockbuster weight-loss drugs could arrive in Canada within months, according to experts. Doctors say these cheaper versions will improve access and could also change societal perceptions around weight loss and reduce the cost and burden on the health-ca...
https://www.cbc.ca/news/health/generic-ozempic-canada-waiting-9.7142339?cmp=rss
As patents on weight-loss drugs expire, doctors and patients hotly anticipate cheaper generics
Now that patents have expired, generic versions of Novo Nordisk's blockbuster weight-loss drugs could arrive in Canada within months, according to experts. Doctors say these cheaper versions will improve access and could also change societal perceptions around weight loss and reduce the cost and burden on the health-ca...
https://www.cbc.ca/news/health/generic-ozempic-canada-waiting-9.7142339?cmp=rss
Molecule in python blood could pave way for new obesity drugs, scientists say

Researchers find snake metabolite that suppresses appetite of obese mice ‘without some of side-effects’ of GLP-1 drugs

The Guardian
Illicit weight loss drug markets aren't just criminal activity—they're market validation signaling extraordinary demand. Our analysis examines the systemic risks and opportunities for $LLY in this paradoxical landscape. https://post.kapualabs.com/c9zbm4th #Pharmaceuticals #SupplyChain #MarketDynamics #WeightLossDrugs
GLP-1 diabetes drugs could stop anxiety and depression worsening, study finds

Drugs such as semaglutide may be useful for mental health conditions associated with diabetes, authors say

The Guardian
What’s behind the injectable peptide craze? – podcast

Madeleine Finlay hears from journalist Adrienne Matei and from Dr Anna Barnard, an associate professor at Imperial College London who researches peptides

The Guardian
The Guardian view on weight-loss jabs and addiction: there is too much moralising about these remarkable medicines

Editorial: Evidence is piling up that GLP-1 drugs can treat addiction. We must learn from the way that obesity has been stigmatised

The Guardian
⚠️ Two deaths. A suicide. And a reporting system that failed. How could this happen with a widely used medication? Click to uncover the full story 👉🏿 https://tinyurl.com/yx8b29p3
#MedicalSafety #GLP1 #WeightLossDrugs #HealthWatch #FDA #Health #Wellness #Ozempic #Wegovy #NovoNordisk #WeightLoss #Diabetes